| Course Name |
Pharmaceutical Development and Regulatory Affairs
|
|
Code
|
Semester
|
Theory
(hour/week) |
Application/Lab
(hour/week) |
Local Credits
|
ECTS
|
|
GBE 450
|
FALL
|
3
|
0
|
3
|
5
|
| Prerequisites | None | |||||
| Course Language | English | |||||
| Course Type | ELECTIVE_COURSE | |||||
| Course Level | First Cycle | |||||
| Mode of Delivery | Face-To-Face | |||||
| Teaching Methods and Techniques of the Course |
Discussion Group Work Case Study Q&A Lecture / Presentation |
|||||
| National Occupational Classification Code | - | |||||
| Course Coordinator |
|
|||||
| Course Lecturer(s) |
|
|||||
| Assistant(s) | - | |||||
| Course Objectives | The aim of this course is to provide background and insight into the managerial, technical and regulatory aspects of pharmaceutical product development, which in today’s world is stemmed from genetic engineering applications. From this perspective, design of experiments on pharmaceutical product development using molecular biology, genetics and bioengineering techniques will be covered. In addition, extra information will be given on the validation studies and manufacturing technologies as well as regulatory affairs. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Learning Outcomes |
The students who succeeded in this course;
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Course Description | This course describes the managerial process of pharmaceutical product development with examples and case studies by highlighting the technical and regulatory challenges. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Sustainable Development Goals |
-
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Core Courses |
|
| Major Area Courses |
X
|
|
| Supportive Courses |
|
|
| Media and Managment Skills Courses |
|
|
| Transferable Skill Courses |
|
| Week | Subjects | Required Materials | Learning Outcome |
| 1 | Product Life Cycle Management: Stages of New Product Development | Pharmaceutical Product Development, 1st edition, Chapter-1 | LO1 |
| 2 | Principal Concepts in Pharmaceutical Product Design and Development | Pharmaceutical Product Development, 1st edition, Chapter-2 | LO1 |
| 3 | Regulatory and Intellectual Property Aspects during Pharmaceutical Product Development | Pharmaceutical Product Development, 1st edition, Chapter-3 | LO3 |
| 4 | Strategies in Pharmaceutical Product Development | Pharmaceutical Product Development, 1st edition, Chapter-4 | LO2 |
| 5 | Design of Experiments: Basic Concepts and Its Application in Pharmaceutical Product Development | Pharmaceutical Product Development, 1st edition, Chapter-5 | LO2 |
| 6 | Preformulation Studies: Role in Pharmaceutical Product Development | Pharmaceutical Product Development, 1st edition, Chapter-6 | LO1 |
| 7 | Midterm exam | - | |
| 8 | Formulation Development and Scale-Up | Pharmaceutical Product Development, 1st edition, Chapter-7 | LO4 |
| 9 | Process Validation and Postapproval Changes | Pharmaceutical Product Development, 1st edition, Chapter-8 | LO3 |
| 10 | Process Validation and Postapproval Changes | Pharmaceutical Product Development, 1st edition, Chapter-9 | LO4 |
| 11 | Packaging of Pharmaceuticals | Pharmaceutical Product Development, 1st edition, Chapter-10 | LO4 |
| 12 | Quality Management Systems in Pharmaceutical Manufacturing | Pharmaceutical Product Development, 1st edition, Chapter-11 | LO4 |
| 13 | A New Era of Drug Products: Opportunities and Challenges | Pharmaceutical Product Development, 1st edition, Chapter-12 | LO5 |
| 14 | Student presentations | LO5 | |
| 15 | Semester Review | - | |
| 16 | Final exam | - |
| Course Notes/Textbooks |
Pharmaceutical product development: insights into pharmaceutical processes management and regulatory affairs. 1st Edition. Edited by Patravale et al. CRC Press. 2016. ISBN: 978-1498730778 |
| Suggested Readings/Materials | Continuous manufacturing of pharmaceuticals. 1st Edition. Edited by Douroumis et al. Wiley. 2017. ISBN: 978-1-119-00132-4 |
| Semester Activities | Number | Weighting | LO1 | LO2 | LO3 | LO4 | LO5 |
| Homework / Assignments | 1 | 30 | X | X | X | ||
| Presentation / Jury | 1 | 20 | X | X | X | ||
| Midterm | 1 | 20 | X | X | X | ||
| Final Exam | 1 | 30 | X | X | |||
| Total | 4 | 100 |
| Semester Activities | Number | Duration (Hours) | Workload |
|---|---|---|---|
| Participation | - | - | - |
| Theoretical Course Hours | 16 | 3 | 48 |
| Laboratory / Application Hours | - | - | - |
| Study Hours Out of Class | 16 | 2 | 32 |
| Field Work | - | - | - |
| Quizzes / Studio Critiques | - | - | - |
| Portfolio | - | - | - |
| Homework / Assignments | 1 | 15 | 15 |
| Presentation / Jury | 1 | 15 | 15 |
| Project | - | - | - |
| Seminar / Workshop | - | - | - |
| Oral Exams | - | - | - |
| Midterms | 1 | 17 | 17 |
| Final Exam | 1 | 23 | 23 |
| Total | 150 |
| # | PC Sub | Program Competencies/Outcomes | * Contribution Level | ||||
| 1 | 2 | 3 | 4 | 5 | |||
| No program competency data found. | |||||||
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest
As Izmir University of Economics transforms into a world-class university, it also raises successful young people with global competence.
More..Izmir University of Economics produces qualified knowledge and competent technologies.
More..Izmir University of Economics sees producing social benefit as its reason for existence.
More..